The Von Willebrand Disease (VWD) Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect and categorize Von Willebrand Disease, a genetic disorder that affects blood clotting. Priced at 6080 AED, this test is crucial for individuals who exhibit symptoms of bleeding disorders or have a family history of VWD. It analyzes various factors including the levels of von Willebrand factor (VWF) and its functionality, which are essential for the proper clotting of blood. By conducting this panel test, healthcare providers can determine the specific type of VWD affecting the patient—ranging from Type 1, the most common and mildest form, to Type 3, the most severe form of the disease. This information is vital for developing an effective treatment plan and managing the condition effectively. DNA Labs UAE employs state-of-the-art technology and follows strict protocols to ensure accurate and reliable test results, making it a trusted choice for patients and healthcare professionals alike.
The Liquid Biopsy 56 Gene Panel Test, offered by DNA Labs UAE, represents a cutting-edge advancement in the field of non-invasive cancer diagnostics. Priced at 6000 AED, this innovative test utilizes a simple blood sample to analyze circulating tumor DNA (ctDNA) for mutations across 56 genes known to be associated with various cancers. This broad-spectrum approach enables healthcare providers to identify genetic mutations that could influence a patient's cancer treatment and management plan without the need for more invasive biopsy procedures. The convenience of a blood draw, combined with the comprehensive nature of the gene panel, makes this test a valuable tool in personalized cancer care, aiding in early detection, monitoring of treatment response, and detection of potential relapses. DNA Labs UAE, by offering this advanced diagnostic solution, plays a pivotal role in enhancing cancer care through precision medicine.
The "Lung Cancer Panel 3 EGFR/ALK1/ROS1/MET Test" is a comprehensive molecular diagnostic test offered by DNA Labs UAE, designed to identify specific genetic mutations associated with lung cancer. This panel focuses on four key genes: EGFR, ALK1, ROS1, and MET, which are known to play significant roles in the development and progression of lung cancer. By analyzing these genes, the test can help determine the most effective treatment options for patients, including targeted therapies that can significantly improve outcomes.
The cost of the Lung Cancer Panel 3 test is 6600 AED. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test involves a detailed examination of the patient's DNA sample to identify mutations in the specified genes. This information is crucial for oncologists to tailor treatment plans to the genetic profile of the tumor, thereby offering a personalized approach to lung cancer treatment. The results from this test can provide valuable insights into the prognosis of the disease and guide decisions regarding the use of specific drugs or treatment regimens, making it a vital tool in the management of lung cancer.
The "Lung Cancer Panel 4 EGFRALK1ROS1METPD L1 Test" is a comprehensive genomic profiling assay performed at DNA Labs UAE, designed to identify specific genetic mutations and alterations in lung cancer patients. This panel targets key genes associated with lung cancer, including EGFR, ALK1, ROS1, MET, and PD-L1, which are crucial for personalized medicine and targeted therapy decisions. By analyzing these genes, oncologists can tailor treatment strategies to the individual's genetic makeup, improving outcomes and minimizing unnecessary treatments. The test cost is 6000 AED, reflecting the sophisticated technology and expertise required to accurately identify these mutations. Conducted at DNA Labs UAE, a facility known for its advanced diagnostic capabilities and commitment to precision medicine, this test represents a significant step forward in the management and treatment of lung cancer, offering hope for more effective and personalized care.
The "Lung Cancer Panel 6 EGFR by Sequencing, ALK by IHC, ROS1 by FISH Test" is a comprehensive diagnostic panel offered by DNA Labs UAE, designed to detect specific genetic mutations and alterations in lung cancer patients. This panel includes three critical tests: EGFR mutation analysis by sequencing, ALK rearrangements by Immunohistochemistry (IHC), and ROS1 rearrangements by Fluorescence in situ hybridization (FISH).
1. **EGFR by Sequencing**: This part of the panel identifies mutations in the EGFR gene, which can influence the growth and spread of cancer cells. Sequencing the EGFR gene helps in determining the eligibility of patients for targeted therapy using EGFR inhibitors.
2. **ALK by IHC**: ALK testing by IHC (Immunohistochemistry) is used to detect rearrangements in the ALK gene. These rearrangements can lead to abnormal cell growth and cancer. Identifying ALK rearrangements is crucial for selecting patients who may benefit from ALK inhibitors, a targeted cancer therapy.
3. **ROS1 by FISH**: The ROS1 portion utilizes Fluorescence in situ hybridization (FISH) to identify rearrangements in the ROS1 gene. Similar to ALK, ROS1 rearrangements are actionable targets in lung cancer treatment, with specific inhibitors available for patients with these genetic alterations.
Priced at 6000 AED, this panel is a valuable tool for the personalized management of lung cancer, enabling healthcare providers to tailor treatment strategies based on the genetic profile of a patient's tumor. Conducted at DNA Labs UAE, a facility known for its cutting-edge technology and expertise in genetic testing, this panel ensures accurate and reliable results, guiding the course of treatment for lung cancer patients towards more effective and targeted therapies.
The "Microarray 60K AFCVSCB and Karyotyping and FISH Chromosome 131821 X and Y Test" is a comprehensive genetic analysis conducted at DNA Labs UAE, a leading facility in the field of genetic diagnostics. Priced at 6000 AED, this test combines several advanced techniques to provide a detailed examination of an individual's genetic makeup.
Microarray 60K AFCVSCB is a high-resolution screening that examines thousands of genetic markers across the entire genome to detect variations associated with various genetic conditions. This method is known for its ability to identify small deletions or duplications that may not be visible through traditional karyotyping.
Karyotyping is a conventional genetic test that involves the examination of chromosomes under a microscope. It is used to detect larger chromosomal abnormalities, such as extra copies of a chromosome or missing chromosomes, which can be linked to genetic diseases or developmental disorders.
FISH (Fluorescence In Situ Hybridization) Chromosome 131821 X and Y Test is a more targeted approach that uses fluorescent probes to visualize specific chromosomes or regions of chromosomes, including the sex chromosomes X and Y, as well as chromosomes 13, 18, and 21. This is particularly useful for diagnosing conditions like Down syndrome (trisomy 21), Patau syndrome (trisomy 13), and Edwards syndrome (trisomy 18), as well as sex chromosome abnormalities.
By combining these three powerful techniques, the test offers a comprehensive genetic analysis, making it a valuable tool for detecting a wide range of genetic disorders. Conducted at DNA Labs UAE, patients can expect state-of-the-art facilities and expert analysis, ensuring accurate and reliable results. The cost of the test, set at 6000 AED, reflects the extensive insights it provides into an individual's genetic health, making it a worthwhile investment for those seeking in-depth genetic screening.
The MPZ Full-Length Gene Sequence Analysis Charcot-Marie-Tooth Disease Test is a specialized genetic test offered by DNA Labs UAE, designed to diagnose and understand Charcot-Marie-Tooth (CMT) disease. This test focuses on analyzing the entire length of the MPZ gene, which is crucial as mutations in this gene are known to cause certain forms of CMT disease. The MPZ gene encodes for myelin protein zero, a critical component of the myelin sheath that insulates nerve fibers. Mutations in this gene can lead to the degeneration of peripheral nerves, resulting in the characteristic symptoms of CMT disease, such as muscle weakness and atrophy, decreased muscle tone, and sensory loss.
Given the complexity and the comprehensive nature of the analysis, the test is priced at 6000 AED. Conducting the test at DNA Labs UAE ensures that patients receive accurate and reliable results, utilizing state-of-the-art genetic sequencing technologies. This detailed genetic insight is invaluable for confirming the diagnosis of CMT, understanding the specific subtype, and guiding treatment and management strategies for affected individuals.
The PIK3CA by NGS (Next-Generation Sequencing) test is a specialized genetic analysis offered by DNA Labs UAE, aimed at detecting mutations in the PIK3CA gene. This gene plays a crucial role in the regulation of cell growth, and mutations within it are often implicated in various cancers, including breast, colorectal, and endometrial cancers. By leveraging the comprehensive and precise approach of NGS technology, this test can identify even minute alterations in the PIK3CA gene, enabling healthcare professionals to make informed decisions regarding prognosis, targeted therapy, and personalized treatment plans for patients.
The cost of the PIK3CA by NGS test at DNA Labs UAE is 6000 AED. This investment in genetic testing is a critical step towards precision medicine, allowing for more tailored and effective treatment strategies, potentially improving patient outcomes in the battle against cancer.
Pre-implantation Genetic Diagnosis (PGD) with HLA Typing is a sophisticated reproductive technology used in conjunction with in vitro fertilization (IVF) to help identify genetic defects within embryos. This process also includes typing of the human leukocyte antigen (HLA) to ensure that the selected embryo can be a potential donor for an existing sibling requiring a stem cell transplant. The single embryo test is meticulously designed to screen for a wide range of genetic disorders and ensure the embryo's compatibility with the HLA type of a family member, significantly increasing the chances of a successful transplant and treatment of genetic diseases.
At DNA Labs UAE, this highly specialized test is offered at a cost of 4400 AED. The lab utilizes cutting-edge technology and adheres to stringent quality standards to provide accurate and reliable results. By opting for the PGD with HLA Typing Single Embryo Test, prospective parents are given a chance to not only bring a healthy child into the world but also potentially save the life of an existing child with a genetic disorder, making it a valuable option for families facing complex genetic health challenges.
The "Liquid Biopsy Lung Cancer Test" is an advanced, non-invasive diagnostic approach offered by DNA Labs UAE, designed to detect and monitor lung cancer using a simple blood sample. Unlike traditional biopsy methods that require tissue samples, this cutting-edge technology analyzes circulating tumor DNA (ctDNA) in the bloodstream to identify genetic mutations and alterations associated with lung cancer. This method provides a quicker, less painful, and more convenient option for patients, potentially leading to early detection and personalized treatment strategies. The test is priced at 6000 AED, reflecting its sophisticated technology and the invaluable insights it offers into the genetic profile of lung cancer, aiding in the optimization of treatment plans and monitoring of disease progression.
